Writing in JAMA, Dr. Cara Tannenbaum, from the University of Montreal and the Canadian Institutes of Health Research, and Dr. Janine Austin Clayton, from the U.S. NIH, note that until recently, most human health research has favored men, despite the fact that women comprise half the population. As a result, they and their colleagues set up the Sex and Gender Equity in Research (SAGER) guidelines that call for new reporting standards for stratifying research data by sex, gender, or both. Women metabolize certain drugs differently than men do, the scientists say, and that by not studying women or by reporting only combined results, we could be missing information critical for women's health.
The results of clinical trials are not always reported for men and women separately. Moreover, a number of researchers erroneously believe that studies conducted only in men can be translatable to women.
Do you agree that research results should be stratified by sex, gender, or both?